InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
0.00%
)
Bitcoin
60,902.67
(
0.98%
)
Post# of 2804248
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

MrDanMan

Send PM Follow Ignore
Followers 6
Posts 108
Boards Moderated 0
Alias Born 08/30/2013

MrDanMan

Re: None

Tuesday, 02/17/2015 9:58:51 AM

Tuesday, February 17, 2015 9:58:51 AM

Post# of 2804248
Sunshine Heart (SSH) expected to report interim study after FDA meeting

By end of February, SSH is announcing the results of meeting with FDA for C-Pulse interim study. This will cut the company's trial time in half as 194 patients will be needed, rather than original 388.

Company is trading in low end of 52 week range, but that could change by end of month

http://finance.yahoo.com/news/sunshine-heart-provides-corporate-103000253.html
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up